Sign in

Guillaume Mestrallet

@gmestrallet.bsky.social
20 followers 40 following 8 posts

Researcher in Immuno-oncology

PostsRepliesMedia
Guillaume Mestrallet @gmestrallet.bsky.social · 16/07/2026
Thanks for sharing our work!
000
Guillaume Mestrallet @gmestrallet.bsky.social · 06/05/2026
Here’s a short audio with accessible explanations of our findings (in English and French): open.spotify.com/show/4gGV2WU...
open.spotify.com
Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer
Spotify video
020
Guillaume Mestrallet @gmestrallet.bsky.social · 05/05/2026
Voici un lien audio de vulgarisation scientifique (5min en français): open.spotify.com/show/4gGV2WU...
open.spotify.com
Reprogrammer le système immunitaire pour vaincre la résistance au cancer colorectal
Spotify video
000
Guillaume Mestrallet @gmestrallet.bsky.social · 05/05/2026
Glad to share our work about resistance to immunotherapy! We discovered a combination therapy allowing to eliminate CRC tumors. We also identified the T cell and macrophage subsets mediating the response. Thanks to the team! www.cell.com/cell-reports... Plus, a small cartoon summarizing the study.
221
Guillaume Mestrallet @gmestrallet.bsky.social · 29/09/2025
We're excited to share our latest work: "Targeting neoantigens conserved across organs and species overcomes tumor immune escape"! Thanks to the team at @sinaiimmuno.bsky.social ! www.biorxiv.org/content/10.1...
biorxiv.org
Targeting neoantigens conserved across organs and species overcomes tumor immune escape
Neoantigen-targeted immunotherapies hold promise for cancer treatment, but current personalized approaches are time-consuming and costly. Here, we identify neoantigens encoded by Ptprs and Igf2r that ...
021
Guillaume Mestrallet @gmestrallet.bsky.social · 15/04/2025
@francoisrousset.bsky.social will give a talk at Mount Sinai Hospital on May 7th. If interested, please do not hesitate to reach out!
010
Guillaume Mestrallet @gmestrallet.bsky.social · 18/02/2025
@sinaiimmuno.bsky.social
000
Guillaume Mestrallet @gmestrallet.bsky.social · 18/02/2025
Glad to share our work about resistance to immunotherapy! We discovered a combination therapy allowing to eliminate 100% of MMRd CRC tumors and >70% or MMRp CRC tumors. We also identified the T cell and macrophage subsets mediating the response. Thanks to the team! www.biorxiv.org/content/10.1...
185